" "

Due to COVID-19, HCA’s lobby is closed. Learn more about HCA's customer service options during the pandemic.

How we work

We'd like to hear from you. Find out how to be involved.

Public participation

  • Phase 1: Topic selection
    Anyone can suggest a topic for the program to investigate. Nominations are sent to the program. The program also considers previous technologies for re-review. Once or twice a year, the program prioritizes all the nominated technologies and selects about ten to undergo review.
  • Phase 2: Key questions
    For selected technologies, the next step is to identify what research questions to ask. The research questions guide the development of the evidence report. Draft and final key questions are published online.
  • Phase 3: Evidence report
    A contracted research organization then reviews submitted information, and searches for, summarizes, and evaluates trials, articles, and other evidence about the topic. A draft and final technology assessment report are produced.
  • Phase 4: Clinical committee meeting and coverage decision
    The evidence report is then used by an independent group of eleven clinicians who practice medicine locally. This committee holds public meetings, usually quarterly, to decide whether and under what circumstances state agencies should pay for the health technology based on whether the evidence shows it is safe, effective and has value.
  • Phase 5: Decision complete
    The process is complete by publishing a draft and then final coverage decision online. State agencies implement the coverage decision. In order to keep pace with changes in health technologies, the program also considers completed technologies for a re-review at least every 18 months.